408 related articles for article (PubMed ID: 12123136)
1. [Risk factors and cardiovascular disease in uremic patients].
Valdés F; Morales JM
Nefrologia; 2002; 22 Suppl 4():1-6. PubMed ID: 12123136
[No Abstract] [Full Text] [Related]
2. [Cardiovascular risk in patients with chronic renal failure. Patients in renal replacement therapy].
Cases A; Vera M; López Gómez JM
Nefrologia; 2002; 22 Suppl 1():68-74. PubMed ID: 11987673
[TBL] [Abstract][Full Text] [Related]
3. [Hypoadiponectinemia: a cardiovascular risk factor in uremia. A view from the evidence].
Estrada PN; Bajo MA; del Peso G; Iglesias P; Díez JJ; Fernández-Reyes MJ; Grande C; Sánchez Hernández R; Selgas R
Nefrologia; 2006; 26(6):653-7. PubMed ID: 17227241
[No Abstract] [Full Text] [Related]
4. Chronic kidney disease as a cardiovascular risk factor.
Best PJ; Holmes DR
Am Heart J; 2003 Mar; 145(3):383-6. PubMed ID: 12660658
[No Abstract] [Full Text] [Related]
5. K/DOQI clinical practice guidelines for cardiovascular disease in dialysis patients.
K/DOQI Workgroup
Am J Kidney Dis; 2005 Apr; 45(4 Suppl 3):S1-153. PubMed ID: 15806502
[No Abstract] [Full Text] [Related]
6. [Evaluation of cardiovascular risk during substitution management: silent cardiopathies].
Machecourt J
Nephrologie; 2000; 21(7):351-2. PubMed ID: 11200609
[No Abstract] [Full Text] [Related]
7. Angiopoietin 2 and cardiovascular disease in dialysis and kidney transplantation.
David S; Kümpers P; Hellpap J; Horn R; Leitolf H; Haller H; Kielstein JT
Am J Kidney Dis; 2009 May; 53(5):770-8. PubMed ID: 19268412
[TBL] [Abstract][Full Text] [Related]
8. Editorial: Neuropathy in uremic patients on dialysis.
Tyler HR
N Engl J Med; 1975 May; 292(20):1075. PubMed ID: 164626
[No Abstract] [Full Text] [Related]
9. Toxic effects of hyperhomocysteinemia in chronic renal failure and in uremia: cardiovascular and metabolic consequences.
Perna AF; Capasso R; Acanfora F; Satta E; Lombardi C; Ingrosso D; Violetti E; Romano MM; De Santo NG
Semin Nephrol; 2006 Jan; 26(1):20-3. PubMed ID: 16412820
[TBL] [Abstract][Full Text] [Related]
10. Relations between concentrations of asymmetric dimethylarginine and neopterin as potential risk factors for cardiovascular diseases in haemodialysis-treated patients.
Avci E; Coskun S; Cakir E; Kurt Y; Ozgur Akgul E; Bilgi C
Ren Fail; 2008; 30(8):784-90. PubMed ID: 18791952
[TBL] [Abstract][Full Text] [Related]
11. Uremic syndrome and end-stage renal disease: physical manifestations and beyond.
Chikotas N; Gunderman A; Oman T
J Am Acad Nurse Pract; 2006 May; 18(5):195-202. PubMed ID: 16681706
[TBL] [Abstract][Full Text] [Related]
12. Controlling the epidemic of cardiovascular disease in chronic renal disease: report from the National Kidney Foundation Task Force on cardiovascular disease.
Meyer KB; Levey AS
J Am Soc Nephrol; 1998 Dec; 9(12 Suppl):S31-42. PubMed ID: 11443766
[No Abstract] [Full Text] [Related]
13. [Cardioprotection: an essential component for predialysis chronic renal failure treatment].
Jungers P; Qualim Z; Nguyen-Khoa T; Massy Z; London G
Nephrologie; 2003; 24(2):79-88. PubMed ID: 12723513
[TBL] [Abstract][Full Text] [Related]
14. Body mass index and cardiovascular risk factors and biomarkers in hemodialysis patients.
Bossola M; Giungi S; Panocchia N; Vulpio C; Luciani G; Tazza L
J Nephrol; 2008; 21(2):197-204. PubMed ID: 18446714
[TBL] [Abstract][Full Text] [Related]
15. [Haemodialysis and hypertension].
van der Giet M; Zidek W
Dtsch Med Wochenschr; 2006 Nov; 131(46):2605-9. PubMed ID: 17096308
[No Abstract] [Full Text] [Related]
16. [Uremic neuropathy in chronic kidney failure with dialysis].
Ogura Y; Chichihara Y
Nihon Rinsho; 1992 Jan; 50 Suppl():824-7. PubMed ID: 1315886
[No Abstract] [Full Text] [Related]
17. Reversible uremic deafness after successful renal transplantation.
Mitschke H; Schmidt P; Kopsa H; Zazgornik J
N Engl J Med; 1975 May; 292(20):1062-3. PubMed ID: 1091857
[No Abstract] [Full Text] [Related]
18. Lipid metabolism in dialysis patients-the story gets more complicated.
Ponda MP; Barash I
Semin Dial; 2008; 21(5):390-4. PubMed ID: 18764791
[TBL] [Abstract][Full Text] [Related]
19. [Oto-rhino-laryngological diseases in patients with advanced kidney failure after kidney transplantation].
Mitschke H
Fortschr Med; 1980 Mar; 98(12):437-40. PubMed ID: 6989724
[TBL] [Abstract][Full Text] [Related]
20. Inflammation in end-stage renal disease--what have we learned in 10 years?
Carrero JJ; Stenvinkel P
Semin Dial; 2010; 23(5):498-509. PubMed ID: 21039875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
